The Latest Cardiac and Vascular News
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. The expansion of the Medical Advisory Board reflects the company’s focus on pulmonary hypertension, coronary artery disease and machine learning. Vallerie V […]
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer. In this role Charles will lead the scientific and clinical development of the CorVista System for commercialization. “We are thrilled to have Charles join […]
Funding to Fuel Development and Commercialization Efforts for Non-Invasive Diagnostic System to Assess for Heart Disease TORONTO–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, today announced it has closed a $65 million Series C equity financing. This latest financing round brings the total cash raised to nearly $100 million. […]
Company Advancing Proprietary Machine Learning to Improve Care in Cardiology TORONTO–(BUSINESS WIRE)–Analytics 4 Life today announced the appointment of Scott Burger to Chief Commercial Officer and Vice President. Scott will lead the commercialization efforts of the CorVista® System, a non-invasive point-of-care solution that allows physicians to rapidly assess heart function. The Company also announced it […]
